Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Hui Guan, Ming Zhong, Kongyang Ma, Chun Tang, Xiaohua Wang, Muzi Ouyang, Rencai Qin, Jiasi Chen, Enyi Zhu, Ting Zhu, Yongping Lu, Yu Liu, Chengzi Tian & Zhihua Zheng. (2023) The Comprehensive Role of High Mobility Group Box 1 (HMGB1) Protein in Different Tumors: A Pan-Cancer Analysis. Journal of Inflammation Research 16, pages 617-637.
Read now
Read now
Carole Burillon, Frederic Chiambaretta & Pierre-Jean Pisella. (2018) Efficacy and safety of glycyrrhizin 2.5% eye drops in the treatment of moderate dry eye disease: results from a prospective, open-label pilot study. Clinical Ophthalmology 12, pages 2629-2636.
Read now
Read now
Articles from other publishers (29)
Bingxia Ming, Yaowu Zhu, Jixin Zhong & Lingli Dong. (2022) Immunopathogenesis of Sjogren's syndrome: Current state of DAMPs. Seminars in Arthritis and Rheumatism 56, pages 152062.
Crossref
Crossref
Julie Sarrand, Laurie Baglione, Dorian Parisis & Muhammad Soyfoo. (2022) The Involvement of Alarmins in the Pathogenesis of Sjögren’s Syndrome. International Journal of Molecular Sciences 23:10, pages 5671.
Crossref
Crossref
Mingkun Chen, Yi Zhou, Miao Xue, Rongrong Zhu, Liling Jing, Liling Lin, Chengwen He & Yanghua Qin. (2022) Anti-HMGB1 antibody is a potential characteristic autoantibody for Sjögren's syndrome. Scientific Reports 12:1.
Crossref
Crossref
Henrik Tonner, Selina Hunn, Nadine Auler, Carsten Schmelter, Vanessa M. Beutgen, Harald D. von Pein, Norbert Pfeiffer & Franz H. Grus. (2022) A Monoclonal Anti-HMGB1 Antibody Attenuates Neurodegeneration in an Experimental Animal Model of Glaucoma. International Journal of Molecular Sciences 23:8, pages 4107.
Crossref
Crossref
Ying-Qian Mo, Hiroyuki Nakamura, Tsutomu Tanaka, Toshio Odani, Paola Perez, Youngmi Ji, Benjamin N. French, Thomas J.F. Pranzatelli, Drew G. Michael, Hongen Yin, Susan S. Chow, Maryam Khalaj, Sandra A. Afione, Changyu Zheng, Fabiola Reis Oliveira, Ana Carolina F. Motta, Alfredo Ribeiro-Silva, Eduardo M. Rocha, Cuong Q. Nguyen, Masayuki Noguchi, Tatsuya Atsumi, Blake M. Warner & John A. Chiorini. (2022) Lysosomal exocytosis of HSP70 stimulates monocytic BMP6 expression in Sjögren’s syndrome. Journal of Clinical Investigation 132:6.
Crossref
Crossref
Yuanji Dong, Bingxia Ming & Lingli Dong. (2022) The Role of HMGB1 in Rheumatic Diseases. Frontiers in Immunology 13.
Crossref
Crossref
Xiuyun Xuan, Lin Zhang, Chunxia Tian, Ting Wu, Haihua Ye, Juanmei Cao, Fangqi Chen, Yan Liang, Huilan Yang & Changzheng Huang. (2021) Interleukin-22 and connective tissue diseases: emerging role in pathogenesis and therapy. Cell & Bioscience 11:1.
Crossref
Crossref
Alyce Alven, Carolina Lema & Rachel L. Redfern. (2021) Impact of Low Humidity on Damage-associated Molecular Patterns at the Ocular Surface during Dry Eye Disease. Optometry and Vision Science 98:11, pages 1231-1238.
Crossref
Crossref
Elisa Menozzi, Eoin Mulroy, Ladan Akbarian-Tefaghi, Kailash P. Bhatia & Bettina Balint. (2021) Movement disorders in systemic autoimmune diseases: Clinical spectrum, ancillary investigations, pathophysiological considerations. Parkinsonism & Related Disorders 88, pages 116-128.
Crossref
Crossref
Muhammad S. Soyfoo & Charles Nicaise. (2021) Pathophysiologic role of Interleukin-33/ST2 in Sjögren's syndrome. Autoimmunity Reviews 20:3, pages 102756.
Crossref
Crossref
Hui Li, Jiangfeng Li, Chenting Hou, Jinjian Li, Hui Peng & Qing Wang. (2020) The effect of astaxanthin on inflammation in hyperosmolarity of experimental dry eye model in vitro and in vivo. Experimental Eye Research 197, pages 108113.
Crossref
Crossref
Di WangMeilan ZhouYan WangShiren Sun. (2020) Suppression of high-mobility group box 1 ameliorates xerostomia in a Sjögren syndrome-triggered mouse model. Canadian Journal of Physiology and Pharmacology 98:6, pages 351-356.
Crossref
Crossref
Se Hyun Choi, Jae Won Oh, Jin Suk Ryu, Hye Min Kim, Sin-Hyeog Im, Kwang Pyo Kim & Mee Kum Kim. (2020) IRT5 Probiotics Changes Immune Modulatory Protein Expression in the Extraorbital Lacrimal Glands of an Autoimmune Dry Eye Mouse Model. Investigative Opthalmology & Visual Science 61:3, pages 42.
Crossref
Crossref
Xuan Qi, Huifang Guo, Chao Sun, Yu Tian, Meng Ding, Yushu Yang & Hongtao Jin. (2020) Clinical significance of progranulin correlated with serum soluble Oxford 40 ligand in primary Sjögren's syndrome. Medicine 99:18, pages e19967.
Crossref
Crossref
Cristian C. Aragón, Julio-Alfredo Llanos, Iván Posso-Osorio, Ivana Nieto-Aristizábal, Natalia Perea-Cardona, Andrés-Felipe Ortiz & Gabriel J. Tobón. (2020) The role of high mobility proteins (HMGB1) in systemic lupus erythematosus. Revista Colombiana de Reumatología (English Edition) 27:1, pages 37-45.
Crossref
Crossref
Cristian C. Aragón, Julio-Alfredo Llanos, Iván Posso-Osorio, Ivana Nieto-Aristizábal, Natalia Perea-Cardona, Andrés-Felipe Ortiz & Gabriel J. Tobón. (2020) Papel de las proteínas de alta movilidad (HMGB1) en el lupus eritematoso sistémico. Revista Colombiana de Reumatología 27:1, pages 37-45.
Crossref
Crossref
Weiqiang Chen, Guoqiang Bao, Lin Zhao & Haichao Wang. 2020. Immune Mediators in Cancer. Immune Mediators in Cancer
15
28
.
Elham Hossny, Dalia El‐Ghoneimy, Dina A. Soliman & Ayman Ashour. (2019) Diagnostic value of serum high‐mobility group box‐1 in pediatric systemic lupus erythematosus. International Journal of Rheumatic Diseases.
Crossref
Crossref
Bin Zhu, Qing Zhu, Nanfang Li, Ting Wu, Shasha Liu & Shanshan Liu. (2018) Association of serum/plasma high mobility group box 1 with autoimmune diseases. Medicine 97:29, pages e11531.
Crossref
Crossref
Anna‐Maria Kanne, Maike Jülich, Amira Mahmutovic, Isabella Tröster, Bettina Sehnert, Vilma Urbonaviciute, Reinhard E. Voll & Florian Kollert. (2018) Association of High Mobility Group Box Chromosomal Protein 1 and Receptor for Advanced Glycation End Products Serum Concentrations With Extraglandular Involvement and Disease Activity in Sjögren's Syndrome. Arthritis Care & Research 70:6, pages 944-948.
Crossref
Crossref
Jessica E. Davies, Bonita H.R. Apta & Matthew T. Harper. (2018) Cross-reactivity of anti-HMGB1 antibodies for HMGB2. Journal of Immunological Methods 456, pages 72-76.
Crossref
Crossref
Kyeong Hwan Kim, Dong Hyun Kim, Hyun Jeong Jeong, Jin Suk Ryu, Yu Jeong Kim, Joo Youn Oh, Mee Kum Kim & Won Ryang Wee. (2017) Effects of subconjunctival administration of anti-high mobility group box 1 on dry eye in a mouse model of Sjӧgren’s syndrome. PLOS ONE 12:8, pages e0183678.
Crossref
Crossref
Chen-Chung Liao, Pei-Lun Chou, Chao-Wen Cheng, Yu-Sheng Chang, Wei-Ming Chi, Kai-Leun Tsai, Wei-Jung Chen, Ting-Shuan Kung, Chih-Chun Tai, Kuan-Wei Lee, You-Chia Chen & Ching-Yu Lin. (2016) Comparative analysis of novel autoantibody isotypes against citrullinated-inter-alpha-trypsin inhibitor heavy chain 3 (ITIH3)542–556 peptide in serum from Taiwanese females with rheumatoid arthritis, primary Sjögren's syndrome and secondary Sjögren's syndrome in rheumatoid arthritis. Journal of Proteomics 141, pages 1-11.
Crossref
Crossref
Sunny Malhotra, Nicolas Fissolo, Mar Tintoré, Ana Cristina Wing, Joaquin Castilló, Angela Vidal-Jordana, Xavier Montalban & Manuel Comabella. (2015) Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis. Journal of Neuroinflammation 12:1.
Crossref
Crossref
Fleur Schaper, Johanna Westra & Marc Bijl. (2014) Recent Developments in the Role of High-Mobility Group Box 1 in Systemic Lupus Erythematosus. Molecular Medicine 20:1, pages 72-79.
Crossref
Crossref
Haichao Wang, Lin Zhao, Jianhua Li, Shu Zhu & Maggie Yeung. 2014. Cytokine Bioassays. Cytokine Bioassays
13
25
.
Fleur Schaper, Peter Heeringa, Marc Bijl & Johanna Westra. (2013) Inhibition of high-mobility group box 1 as therapeutic option in autoimmune disease. Current Opinion in Rheumatology 25:2, pages 254-259.
Crossref
Crossref
Sonal Mehra, Jennifer Walker, Karen Patterson & Marvin J. Fritzler. (2013) Autoantibodies in systemic sclerosis. Autoimmunity Reviews 12:3, pages 340-354.
Crossref
Crossref
Eileen M Bauer, Richard Shapiro, Han Zheng, Ferhaan Ahmad, David Ishizawar, Suzy A Comhair, Serpil C Erzurum, Timothy R Billiar & Philip M Bauer. (2012) High Mobility Group Box 1 Contributes to the Pathogenesis of Experimental Pulmonary Hypertension via Activation of Toll-like Receptor 4. Molecular Medicine 18:12, pages 1509-1518.
Crossref
Crossref